RGT, a synthetic peptide corresponding to the integrin 3 cytoplasmic C-terminal sequence, selectively inhibits outside-in signaling in human platelets by disrupting the interaction of integrin IIb 3 with Src kinase

Published 2008 View Full Article

Authors

Keywords

Journal

BLOOD

Volume 112, Issue 3, Pages 592-602

Publisher

American Society of Hematology

Online

2008-04-09

DOI

10.1182/blood-2007-09-110437

Ask authors/readers for more resources

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started

BLOOD

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Create your own webinar

Ask a Question. Answer a Question.